Nebivolol 5 mg to Metoprolol Dose Equivalence
Nebivolol 5 mg is approximately equivalent to metoprolol tartrate 100 mg twice daily or metoprolol succinate 100-200 mg once daily. 1
Dose Equivalence Rationale
According to the ACC/AHA guidelines, the usual dose ranges for these beta blockers are:
- Nebivolol: 5-40 mg once daily
- Metoprolol tartrate: 100-200 mg twice daily
- Metoprolol succinate: 50-200 mg once daily 1
The starting dose of nebivolol (5 mg) falls at the lower end of its therapeutic range, while equivalent metoprolol dosing would be:
- Metoprolol tartrate: 100 mg twice daily
- Metoprolol succinate: 100-200 mg once daily
Formulation Considerations
Metoprolol Tartrate vs. Succinate
- Metoprolol tartrate is an immediate-release formulation requiring twice-daily dosing
- Metoprolol succinate is an extended-release formulation allowing once-daily dosing
- A 100 mg metoprolol succinate tablet contains 95 mg of metoprolol succinate and is considered equivalent to 100 mg metoprolol tartrate 2
Clinical Implications
- Metoprolol succinate provides more consistent plasma concentrations over 24 hours
- Once-daily dosing with metoprolol succinate improves medication adherence compared to twice-daily regimens with metoprolol tartrate 3
Pharmacological Differences
Despite both being beta-blockers, nebivolol and metoprolol have important differences:
Mechanism of action:
Metabolic effects:
- Metoprolol may decrease insulin sensitivity and increase oxidative stress
- Nebivolol has been shown to have neutral metabolic effects 6
Beta-blocking potency:
- Peak beta-blocking effects of bisoprolol appear stronger than nebivolol and carvedilol
- Nebivolol exhibits a higher trough-to-peak ratio than bisoprolol 5
Clinical Considerations
When switching between these medications:
- Monitor blood pressure and heart rate closely after changing medications
- Consider that nebivolol may have better tolerability than metoprolol, with adverse event rates similar to placebo 7
- Be aware that the vasodilatory properties of nebivolol may provide additional benefits in certain patient populations
Cautions and Contraindications
Both medications are contraindicated in:
- Severe bradycardia
- High-grade AV block without pacemaker
- Cardiogenic shock
- Decompensated heart failure 1
Use with caution in patients with:
- Asthma or COPD
- Diabetes
- Compensated heart failure 3
Remember that abrupt cessation of either beta-blocker should be avoided to prevent rebound hypertension or worsening of underlying cardiac conditions.